HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katia Alves Selected Research

P-300

4/2018Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
4/2018Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
1/2018Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katia Alves Research Topics

Disease

12Infections
11/2022 - 11/2013
5Fibrosis (Cirrhosis)
11/2022 - 01/2018
3Chronic Hepatitis C
11/2015 - 11/2013
2Anemia
01/2017 - 11/2013
1Chronic Hepatitis B
11/2022
1Viremia
01/2022
1Nasopharyngitis
01/2017
1Virus Diseases (Viral Diseases)
11/2015
1Disease Progression
01/2015
1Hepatitis C
10/2011

Drug/Important Bio-Agent (IBA)

6ombitasvirIBA
02/2019 - 11/2015
6paritaprevirIBA
02/2019 - 11/2015
5Ribavirin (Virazole)FDA LinkGeneric
02/2019 - 11/2013
5Ritonavir (Norvir)FDA Link
02/2019 - 11/2015
4glecaprevir and pibrentasvirIBA
04/2018 - 01/2018
3Antiviral Agents (Antivirals)IBA
02/2019 - 11/2015
3P-300IBA
04/2018 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
11/2022 - 01/2022
2dasabuvirIBA
02/2019 - 10/2018
2InterferonsIBA
10/2018 - 01/2018
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2015 - 11/2013
1Hepatitis B e AntigensIBA
11/2022
1entecavirFDA Link
11/2022
1Reverse Transcriptase InhibitorsIBA
11/2022
1Pharmaceutical PreparationsIBA
02/2019
1glecaprevirIBA
01/2018
1pibrentasvirIBA
01/2018
1Protease Inhibitors (Protease Inhibitor)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1BilirubinIBA
01/2017
1lomibuvirIBA
07/2014
1telaprevirIBA
07/2014
1NucleosidesIBA
07/2014
1ErythropoietinFDA Link
11/2013
1Amlodipine (Norvasc)FDA LinkGeneric
10/2011
1Atorvastatin (Lipitor)FDA Link
10/2011
1Cytochrome P-450 CYP3AIBA
10/2011

Therapy/Procedure

2Therapeutics
01/2015 - 11/2013
1Aftercare (After-Treatment)
01/2015
1Drug Tapering
11/2013